Aim: To compare the efficacy, safety and satisfaction of Rollerball ablation (RBA) with that of levonorgestrel intrauterine system (LNG-IUS) in control of heavy menstrual bleeding (HMB).
Introduction
Heavy menstrual bleeding (HMB) or menorrhagia is a complaint in 30% of women and accounts for up to 10% of all gynecological referrals. Also, HMB is a debilitating problem that significantly burden women, their families and society as a whole (1) .
Menorrhagia is the consequence of a variety of functional, nonstructural and pathological conditions. Among the pathological the main causes are adenomyosis and fibroids. Coagulopathies and iatrogenic causes categorized as non-structural conditions. In a substantial proportion of women, the HMB cause remains unknown and is referred to as functional or idiopathic menorrhagia (2) .
Medical therapy including oral contraceptive pill, progestagens as well as non hormonal therapy with tranexamic acid or non-steroidal antiinflammatory drugs (NSAID) are advised as first line treatment where no definitive organic causes are identified. However most women aren't willing to continue their treatment and usually elect to other treatment even surgical (3, 4) .
Hysterectomy has traditionally been regarded as the definitive surgical treatment for HMB and recently hysterectomy has been reported to be the cost effective therapy for HMB (5, 6) . However, hysterectomy is the major surgical procedure with significant physical, emotional sequelae as well as social and economic burdens (5, 6) . So many women asked for less invasive treatment modality even after they are counseled regarding that treatment success is not always assured (7) .
Levonorgestrel intrauterine system (LNG-IUS) and endometrial ablation (EA) are two frequently less invasive treatment for HMB chosen by women (6, 7) .
The effectiveness of ING-IUS on HMB was reported to reduce menstrual blood loss by 79-90% (8, 9, 10, 11) . The RCOG guideline recommends LNG-IUS after failed medical treatment despite unproven cost-effectiveness (12) . Substantial proportion (up to 60%) of women discontinues using LNG-IUS within 5 years due to unscheduled bleeding, pain and/or systemic progestrogenic side effects (12) .
Endometrial ablation (EA) is an effective minimally invasive surgical procedure that has become a well established alternative to medical treatment or hysterectomy to mange menorrhagia in selected cases (6) . However EA is under utilized as most of non-resectoscopic endometrial ablations are not available in developing countries and their disposable is so costly. Moreover due to high risks associated with monopolar resectoscopic endometrial resection and its outcomes, which are operator dependent, Rollerball ablation (RBA) is chosen in this study as its results are less operator dependent (1, 4, 5, 27) . Several trials compared LNG-IUS with transcervical endometrial resection (TCER) or balloon thermal ablation (BTA). However the trials are small, with short period of follow up and contain a lot of noncompliance, this makes interpretation of outcome difficult (10, 14, 15, 16, 17, 18, 19) .
This trial was conducted to compare LNG-IUS with RBA regards efficacy, safety and satisfaction due to lack of adequate research covering this area.
Patients and Methods
This prospective trial was an open label, randomized controlled trial, conducted at Department of obstetrics and gynecology, Benha University Hospital, Benha Egypt, between October 2014 and March 2017. Patients enrolled in this study consecutively and were eligible to be included if they were older than 35 years and less than 45 years, had no desire for future fertility, complaining of HMB with pictorial bleeding assessment chart (PBAC) score >100 with failed medical treatment (20) . Exclusion criteria were sonographic abnormality as submucosual leiomyoma, intramural fibroid more than 3 cm in diameter, large subserosal leiomyoma or endometrial polyp, if transvaginal ultrasound (TVS) was not confirmatory, a saline sonohysterography would be performed, acute pelvic inflammatory disease, gynecologic precancerous lesions as cervical intraepithelial neoplasia, atypical endometrial hyperplasia, gynecological cancer, adenomyosis, severe dysmenorrhea, severe premenstrual pain, chronic pelvic pain, medical contraindication to LNG-IUS and RBA, previous transcervical endometrial resection (TCER), uninvestigated postcoital bleeding and untreated abnormal cervical cytology. All women whom participated in this trial provided written informed consent. Also, Ethical approval for the trial was obtained from Benha Faculty of Medicine ethical committee.
All participants were subjected to a detailed clinical history, as completed physical examination including PBAC scoring (20) . All preoperative investigations were undertaken including CBC, cervical smear, transvaginal ultrasonography, saline sonohystrography and endometrial sampling.
The short form-36 (SF-36) is a questionnaire instrument which was used to assess the patient quality of life before and after the procedures. The SF-36 consists of 36 questions grouped into eight health-related aspects of the patient's quality of life. The SF-36 assesses a full range of health states and includes multi-item scales, evaluating each health concept including: physical functioning (PF), role limitations due to physical health (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE) and mental health (MH). From question under each of the eight groups considered, item scores are coded, summed and transformed to a scale ranging from 0 (worst health status) to 100 (best health status). It has been used in various settings with different population groups and with both medical and psychiatric conditions. Researches have shown that, the SF-36 is a valid and reliable measuring tool for assessing differences between groups defined by age, sex, socioeconomic status and clinical condition (21, 22) .
Both RBA procedures and LNG-IUS (Mirena®, Schering Co., Turku, Finland) insertions were done by the author, the RBA procedures were done under spinal anesthesia with sedation after 4 -6 weeks of oral cidolut nor 5mg every 6 hour (Cid-Egypt) to induce endometrial thinning, while the LNG -IUS insertions were inserted without anesthesia after assessing uterine cavity length with sound as per manufacturers instructions, with aids of TVS.
RBA was performed by 26F rigid resectoscope of KARL STORZ (Tuttingen -Germany) equipped with a Hopkins 30 optic. Glycine 1.5% was used with hysteromat of KARl STORZ to distend the uterine cavity. The fluid deficit was considered to be, the difference between used bottles and the collected in suction container with that suspected to be lost. A deficit up to 1000 ml Glycine was considered the limit after which the procedure was stopped. The rollerbar was used to coagulate the whole uterine cavity and Rollerball to coagulate the fundus and the uterine cornea with 80-w coagulation current.
Follow up was under taken at 3, 12, 24 months after RBA procedures and ING-IUS insertions to assess the menstrual blood loss by PBAC score (20) (standardized sanitary products were arranged to be used during fulfillment of PBAC score in order to allow for comparisons of the PBAC score to be made), quality of life by SF-36 questionnaire (21, 22) and patient's satisfaction by 5 point Likert's scale of very satisfied (5 points), satisfied (4 points), border line (3 points), unsatisfied (2 points), very unsatisfied (1 point). Failure of treatment was considered if a major change in treatment was occurred. In RBA arm, is initiation of medication or another alternative therapy or hysterectomy while in LNG-IVS arm, is loop spontaneous expulsion or elective removal or initiation of alternative treatment modality. If women didn't complete PBAC score, SF-36 questionnaire to the end of the study, the patient's last measured response would be applied to the subsequent scheduled observations for which data were not available (24) .
Participants were randomly allocated into two groups (LNG-INS and RBA) in a 1: 1 ratio using closed enveloped method. Women, data collectors were not blind to group assignment after randomization, as it was not possible.
The primary outcome measures of this study were the evaluation of the efficacy of RBA and LNG -IUS in reduction of HMB as measured with PBAC score and the increase of hemoglobin values. Secondary outcome measures were the evaluation of the safety, satisfaction of RBA and LNG-IUS with SF-36 and 5 points satisfaction scale as well as procedures related complications treatment failures and need for hysterectomy over 2 year follow up period.
Statistical analysis
Continuous variables were presented in terms of mean, stander deviations and ranges while categorical variables were presented in terms of frequencies and percents. Student's t test for paired sample and independent samples were used to compare continuous variables as baseline demographic, clinical criteria, changes in PBAC score, changes in hemoglobin values and changes in SF-36 score. Fisher's exact test was used to compare categorical variables as amenorrhea rate and satisfaction rate. P values as well as mean difference with 95% confidence intervals (CIs) were used to determine significance, P < 0.05 was considered statistically significant. Statistical analysis was conducted using the IBM SPSS (Version 23, 2015) for Windows statistical package. P value <0.05 was considered statistically significant.
Results
In this trial, 110 women were assessed in gynecology outpatient clinic, twenty women (18.1% of women assessed) were excluded from this study while 6 (5.4%) women declined to participate. These 20 women were excluded as they had TVS abnormalities (9 women had submucous leiomyoma, 4 women had endometrial polyp, 3 had adenxal Mass and 4 women had atypical endometrial hyperplasia. Eighty-four women were eligible and were randomized into two equal groups: RBA and LNG-IUS (Fig. 1) . Objectively assessed menstrual blood loss measured by PBAC score was significantly decreased in both trial arms compared with the preintervention scores (P < 0.0001). At 3,6 months PBAC scores were significantly lower in RBA than LNG-IUS group but there was no significant difference between the two groups as regards PBAC scores at 12, 24 months as well as the mean difference between pretreatment scores and 24 months scores. A similar trend was also noticed as regards the amenorrhea rates, as at 3 months the rate of amenorrhea was significantly higher in RBA group than LNG-IUS group while after that the rate of amenorrhea increased in ING-IUS group despite the fact that it didn't reach significant level (Table 2) . Following RBA and ING-IUS, statistically significant increase in hemoglobin were noted during the study period, in RBA group preoperative mean hemoglobin was 9.4  1.4 g/dl raised to 12.9  0.6 g/dl, at 24 months (P < 0.0001). While in ING -IUS group it was raised from 8.9  1.3 g/dl to 12.7  0.3 g/dl at the same study period (P < 0.0001). While there was no significant difference between both groups regards the mean rise in hemoglobin (P = 0.34), (Table 2) . Quality of life was evaluated with SF-36 questionnaire at enrollment, 3, 6, 12, 24 months. For women who failed the treatment and those who were lost to follow the SF-36 at time of last evaluation were utilized in subsequent evaluation as a proxy for their quality of life if they continued with treatment. Table (4) presents mean SF-36 for overall and for each treatment arm and shows that both treatments improve quality of life starting from 3 months after treatment and maintained through the time frame of the study (P<0.0001), however there were no significant differences between treatment at any evaluation point. Participants' evaluation regards satisfaction and recommendation of their treatment to their friends is presented in table (5) and shows that there were no statistically significant differences between the two treatment arms. Treatments failures were evaluated at 3, 6, 12, 24 months as shown in figure (1) . In RBA arm, nine (21.4%) treatment failures, two at 3 months, three at 12 months and four at 24 months, 8 (19%) of them with HMB and one with severe dysmenorrhea. In LNG-IUS there were 8 (19%) treatment failures two at 3 months due to ING-IUS expulsion while three (7.1%) at 12 months with election to remove the LNG-IUS due to unscheduled bleeding and 3 at 24 month due to HMB. Among, the eight treatment failures with ING-IUS arm, 3 (7.1%) opt to do EA with TCER during the study period and five (11.9) chosen hysterectomy while in nine treatment failures with RBA, 6 (14.2%) underwent hysterectomy and three (7.1%) chosen to repeat EA with TCER during the study period. No complication from RBA procedures or LNG-IUS insertions were reported during the study period.
Discussion
In this current prospective study two well known treatment modalities for HMB were compared directly to each other as after careful reviewing of literatures, direct comparison between hysteroscopic RBA and LNG-IUS couldn't be found. However there are numerous studies comparing LNG-IUS with hysteroscopic TCER (10, 16, 25, 26) as well as comparing LNG-IUS with 2 nd generation EA procedures as thermal ball ablation (15, 17, 18, 19) and a current on going trial comparing LNG-IUS with Novasure EA (23) .
The LNG -IUS is a T shaped polyethylene frame (32 mm x 32mm). Its vertical stem contains a 1:1 mixture of 52 mg of levonorgestrel (LNG) and polydimethsiloxane. Over 5 years, LNG -IUS delivers 20 mg LNG into uterine cavity, hence reach systemic circulation with steady serum level of 150 -200 pg/ml, hence its systemic progestogenic side effects. The LNG -IUS induced endometrial atrophy resulting in controlling HMB beside its contraceptive effect as well as it major advantage over the EA procedures which is the reversibility (1, 3, 5, 8, 9, 12) .
Rollarball ablation is hysteroscopic EA procedure when compared to TCER it is less operator dependent as well as it is easier and with fewer associated sequels (1, 4, 5, 27) .
Assessment of RBA versus LNG-IUS through literatures could be made indirectly. Soysal et al. (13) as well as Loffer (28) comparing RBA versus TBA with thermo-choice, the first in setting with myoma induced HMB while the second in setting of functional HMB. Both trials reported that similar successful results obtained with both EA procedures at short term (13) as well as long term following (28) .
Indirectly, the results of this trial are in agreement with that of Soysal et al. (19) where they compared LNG-IUS versus TBA on 72 women and they found that at 12 months post treatment the reduction of PBAC scores was significantly greater in TBA ( PBAC 388.2  21 versus 343  27, P < 0.001). However no significant difference were reported as regards mean changes in hemoglobin values as well as regards health related quality of life as assessed by SF-36. However, Borrington et al. (17) compared LNG-IUS versus TBA on 50 women and reported similar effectiveness of both procedures despite no significance difference regards PBAC score at 6 months post treatment. In this study hysterectomy rate after both procedures was equal 3/25 in LNG-IUS arm versus 5/25 in TBA arm. Busfield et al. randomized 83 women into LNG-IUS (42) and TBA (41) and reported results on 79 women as 3 were excluded. They found that both procedures were effective in control of HMB but the long term results in control of PBAC scores were significant with LNG-IUS when compared TBA (mean PBAC at 24 months 20  28.8 versus 75  91 with P = 0.002). However similar results with no significance difference were reported on quality of life assessed with SF-36 questionnaire.
Also, Soysal and Soysal (29) compared 32 insertions of LNS-IUS with 32 historical control of TBA in selected case of myoma-related HMB and they reported that slower step wise reduction in PBAC scores as well as a slower stepwise increase in hemoglobin values in LNG-IUD arm but they reported earlier significant difference in reduction of PBAc scores and increase in hemoglobin values at 3 months post treatment evaluation despite no significant difference as regards these items in repeated follow up at 6 and 12 months. The earlier results in favor of RBA in this study could be explained by pretreatment induction of Endometrial thinking in RBA arm while the slower stepwise effect in LNG-IUS arm may be related to the additive temporal effects of sustained release of LNG on the endometrium as the local antiproliferative effect of LNG increases over time results in bleeding decreases over time.
Hysterectomy is gold stander in achieving 100% cessation of HMB when compared to Medical or conservative procedures, However randomized studies on quality of life reported higher improvement in LNG-IUS arm in spite of continuing bleeding (29) . Trials comparing LNG-IUS with hysterectomy (30, 31) , found despite the fact that 50 (42%) of 119 women randomized to LNG-IUS eventually underwent hysterectomy the satisfaction rates were similar in both groups. In these trials the rates of hysterectomy were similar between both groups and the overall rates of hysterectomy 11/82 (13%) were less than those reported in trials of hysterectomy versus LNC-IUS as women in the study comparing hysterectomy with LNG-IUS were willing to consider hysterectomy at trial entry and so they were a different population from those entering a trial evaluating conservative ablation therapy, namely RBA with LNG-IUS. A systematic review of five randomized controlled trials comparing TCER with hysterectomy (6) found that both procedures are effective and satisfaction rates are high in both, despite the fact that hysterectomy is with high complications, sequales and costs (6) . Several trials compared second generation EA with TCEA and RBA (13, 28, 32, 33, 34, 35, 36) and didn't show any significant difference in term of efficacy.
This trial was randomized prospective controlled study covering the direct comparison between RBA and LNG -IUS and extends to 24 months follow when compared to Most randomized and observational studies which were relatively small and with relatively shorter duration of follow up which is usually 12 months. However, these trials may be under powered to detect other items which may be important to be evaluated regard LNG-IUS as expulsion rates and hysterectomy rates differences between EA procedures and LNG -IUS insertions for treatment of HMB.
Conclusion
This study has shown the LNG -IUS insertion results in comparable stepwise decrease in mean PBAC scores as well as increase in hemoglobin values when compared to RBA. Also both treatment modalities are associated with similar high level of patient satisfaction and quality of life. Furthermore, up to 13% of women were treated with these modalities for HMB underwent hysterectomy. Neither treatment of them was superior to other in term of efficacy, safety and satisfaction, and treatment choice should be tailored base on surgeon skill, as well as the individual women preference.
